Common Hereditary Cancers and Cancer Syndromes
Breast and Ovarian Cancer (BRCA1, BRCA2)
Colon Cancer (APC, BMPR1A, EPCAM)
Lynch Syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM)
Uterine Cancer (MLH1, MSH2, EPCAM, MSH6, PMS2)
Li-Fraumeni Syndrome (TP53)
Endometrial Cancer (EPCAM, MLH1, MSH2, MSH6)
Who Can Benefit from the Hereditary Cancer Risk Assessment?
An individual with, or had, more than one cancer.
An individual with a personal history of cancer with limited availability of family history and single-gene testing has not found a mutation, or the result is uncertain.
An individual who has multiple close family members with a cancer diagnosis under the age of 50.
An individual with three@ or more close family members with different types of cancer.
An individual with family members who have taken a cancer genetic test and mutations were identified.
An individual being a member of a racial or ethnic group that is known to have an increased risk of having a certain inherited cancer susceptibility syndrome.
An individual with a personal or family history of cancer and single-gene testing has not found a mutation, or the result is uncertain.
An individual with rare or unusual cancer presentations.
Why Should Patients Get Tested?
Patients may begin to get cancer screens earlier and more often.
Patients may begin to monitor themselves closely for signs or symptoms of a particular type of cancer.
Patients may initiate healthy lifestyle changes.
Patients may look in to preventive medications or surgery if recommended by a healthcare provider.
Cancer Genomics (CGx)
Assess a patient's risk of developing certain cancers due to inherited gene mutations.